BACKGROUND: The aim of this paper was to study the evolution of primary Sjögren's syndrome (pSS) immunological profile, its impact on pSS activity and long-term evolution in a bicentric cohort of French patients with pSS (n = 445, mean age 53.6 ± 14 years, mean follow-up 76.1 ± 51 months). METHODS: This is a retrospective cohort study. RESULTS: Two hundred twelve patients were Sjögren's syndrome A (SSA) positive, and 131 were both SSA and Sjögren's syndrome B (SSB) positive. Sixty-eight patients (15%) had cryoglobulinemia. Active systemic profile (i.e., hypergammaglobulinemia, rheumatoid factor (RF), and anti-Sjögren's syndrome A (anti-SSA), anti-Sjögren's syndrome B (anti-SSB) positivity), associated with multisystemic involvement, leads to an increased utilization of corticosteroid and hydroxychloroquine. Multivariate analysis pointed out independent statistical association between hypergammaglobulinemia, anti-SSA, anti-SSB, and RF. Cryoglobulinemia is associated with multi-systemic involvement, lymphoma, and pSS-related death. CONCLUSION: The subset of patients with active immunological profile is characterized by systemic complications leading to immunosuppressive drug utilization and polyclonal B-cell activation profile.
BACKGROUND: The aim of this paper was to study the evolution of primary Sjögren's syndrome (pSS) immunological profile, its impact on pSS activity and long-term evolution in a bicentric cohort of French patients with pSS (n = 445, mean age 53.6 ± 14 years, mean follow-up 76.1 ± 51 months). METHODS: This is a retrospective cohort study. RESULTS: Two hundred twelve patients were Sjögren's syndrome A (SSA) positive, and 131 were both SSA and Sjögren's syndrome B (SSB) positive. Sixty-eight patients (15%) had cryoglobulinemia. Active systemic profile (i.e., hypergammaglobulinemia, rheumatoid factor (RF), and anti-Sjögren's syndrome A (anti-SSA), anti-Sjögren's syndrome B (anti-SSB) positivity), associated with multisystemic involvement, leads to an increased utilization of corticosteroid and hydroxychloroquine. Multivariate analysis pointed out independent statistical association between hypergammaglobulinemia, anti-SSA, anti-SSB, and RF. Cryoglobulinemia is associated with multi-systemic involvement, lymphoma, and pSS-related death. CONCLUSION: The subset of patients with active immunological profile is characterized by systemic complications leading to immunosuppressive drug utilization and polyclonal B-cell activation profile.
Authors: C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman Journal: Ann Rheum Dis Date: 2002-06 Impact factor: 19.103
Authors: M Ramos; R Cervera; M García-Carrasco; C Miret; F J Muñoz; G Espinosa; J Font; M Ingelmo Journal: Med Clin (Barc) Date: 1997-05-03 Impact factor: 1.725
Authors: Anne-Laure Fauchais; Bali Ouattara; Guillaume Gondran; Fabrice Lalloué; Daniel Petit; Kim Ly; Marc Lambert; David Launay; Véronique Loustaud-Ratti; Holly Bezanahari; Eric Liozon; Eric Hachulla; Marie-Odile Jauberteau; Elisabeth Vidal; Pierre-Yves Hatron Journal: Rheumatology (Oxford) Date: 2010-03-18 Impact factor: 7.580
Authors: G L Schall; L G Anderson; R O Wolf; J R Herdt; T M Tarpley; N A Cummings; L S Zeiger; N Talal Journal: JAMA Date: 1971-06-28 Impact factor: 56.272
Authors: Manuel Ramos-Casals; Juan-Manuel Anaya; Mario García-Carrasco; José Rosas; Albert Bové; Gisela Claver; Luis-Aurelio Diaz; Carmen Herrero; Josep Font Journal: Medicine (Baltimore) Date: 2004-03 Impact factor: 1.889
Authors: Evangelia Baimpa; Issa J Dahabreh; Michael Voulgarelis; Haralampos M Moutsopoulos Journal: Medicine (Baltimore) Date: 2009-09 Impact factor: 1.889
Authors: Natalia V Giltiay; Yi Lu; Jaime L Cullen; Trine N Jørgensen; Mark J Shlomchik; Xiaoxia Li Journal: J Immunol Date: 2013-07-31 Impact factor: 5.422
Authors: Barbara M Segal; Brian Pogatchnik; Lisa Henn; Kyle Rudser; Kathy Moser Sivils Journal: Arthritis Care Res (Hoboken) Date: 2013-08 Impact factor: 4.794
Authors: Maria B Nishishinya; Claudia A Pereda; Santiago Muñoz-Fernández; José M Pego-Reigosa; Iñigo Rúa-Figueroa; José-Luis Andreu; Mónica Fernández-Castro; José Rosas; Estibaliz Loza Santamaría Journal: Rheumatol Int Date: 2014-06-05 Impact factor: 2.631